What is Deere & Company's earnings per share (EPS)?

Deere & Company (DE) reported diluted earnings per share of $18.50 for fiscal year 2025. This represents a -27.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Deere & Company (DE) Financials

Trailing 12 months to August 2, 2026

Revenue $46.9B +5.5% YoY

Net Income $5.1B -2.3% YoY

EPS (Diluted) $18.00 -6.1% YoY

Free Cash Flow $6.0B -15.3% YoY

Market Cap $167.4B as of Oct 10, 2026

Price / Sales 3.6x on $46.9B revenue, trailing 12 months to August 2, 2026

Price / Earnings 32.9x on $5.1B net income, trailing 12 months to August 2, 2026

Price / Book 6.0x on $28.0B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Aug 2, 2026 Reported Aug 27, 2026 Currency USD FYE November

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DE SEC filings page.

Deere & Company (DE) reported $46.9B in revenue over the twelve months to Aug 2, 2026, up 5.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DE FY2025 2026-10-03

Deere remains cash-generative through a downturn, but lower earnings and heavier financing costs are compressing returns.

From FY2023 to FY2025, revenue contracted while net margin fell from 16.6% to 11.0%, showing a cyclical earnings reset rather than merely slower expansion. Yet free-cash-flow margin improved from 11.6% to 13.4% as capital spending eased, so cash generation was less impaired than accounting profitability.

In FY2025, free cash flow of $6.10B exceeded net income of $5.03B; this gap means non-cash charges and working-capital timing materially shape reported cash. Annual earnings are therefore a weaker standalone guide to cash available for reinvestment than the cash-flow lines.

FY2025 liabilities stood at 3.1x equity, down from 3.7x in FY2024, indicating improved balance-sheet support relative to equity while the business remains predominantly liability-financed. Interest expense had risen to $3.35B by FY2024 from $993M in FY2021, increasing financing's claim on operating earnings before the latest downturn.

Financial Health Signals

Financial Health Score 32/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Deere & Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

Deere & Company's revenue declined 11.7% year-over-year, from $51.7B to $45.7B. This contraction results in a growth score of 7/100.

Leverage

Deere & Company has elevated debt relative to equity (D/E of 3.08), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 21/100, reflecting increased financial risk.

Liquidity

Not available for Deere & Company, and counted as zero in the overall score.

Cash Flow

Deere & Company converts 13.4% of revenue into free cash flow ($6.1B). This strong cash generation earns a score of 74/100.

Returns

Not available for Deere & Company, and counted as zero in the overall score.

Piotroski F-Score Partial

4/6

Deere & Company passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.48x

For every $1 of reported earnings, Deere & Company generates $1.48 in operating cash flow ($7.5B OCF vs $5.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$12.6B

YoY+4.9%

QoQ-5.7%

5Y CAGR+1.8%

10Y CAGR+6.5%

Deere & Company generated $12.6B in revenue in Q3 2026. This represents an increase of 4.9% from the same quarter a year earlier. Against the prior quarter it is down 5.7%.

Net Income

$1.4B

YoY+7.0%

QoQ-22.2%

5Y CAGR-3.7%

10Y CAGR+10.9%

Deere & Company reported $1.4B in net income in Q3 2026. This represents an increase of 7.0% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.

EPS (Diluted)

$5.10

YoY+7.4%

QoQ-22.1%

5Y CAGR-0.8%

10Y CAGR+12.6%

Deere & Company earned $5.10 per diluted share (EPS) in Q3 2026. This represents an increase of 7.4% from the same quarter a year earlier. Against the prior quarter it is down 22.1%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

$1.9B

YoY-25.2%

QoQ+11.9%

5Y CAGR-3.8%

10Y CAGR+2.7%

Deere & Company generated $1.9B in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 25.2% from the same quarter a year earlier. Against the prior quarter it is up 11.9%.

Cash & Debt

$8.9B

YoY+4.1%

QoQ+12.9%

5Y CAGR+3.5%

10Y CAGR+7.5%

Deere & Company held $8.9B in cash as of Q3 2026; long-term debt is not reported for that period.

Dividends Per Share

$1.62

YoY0.0%

QoQ0.0%

5Y CAGR+12.5%

10Y CAGR+10.4%

Deere & Company paid $1.62 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

270M

YoY-0.3%

QoQ-0.1%

5Y CAGR-2.8%

10Y CAGR-1.5%

Deere & Company had 270M shares outstanding in Q3 2026. This represents a decrease of 0.3% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Margins & Returns

Net Margin

10.9%

YoY+0.2pp

QoQ-2.3pp

5Y change-3.5pp

10Y change+3.7pp

Deere & Company's net profit margin was 10.9% in Q3 2026, showing the share of revenue converted to profit. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.3 percentage points.

Return on Equity

4.9%

YoY-0.2pp

QoQ-1.5pp

5Y change-5.7pp

10Y change-1.7pp

Deere & Company's ROE was 4.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending

$567.0M

YoY+2.0%

QoQ-2.7%

5Y CAGR+7.6%

Deere & Company invested $567.0M in research and development in Q3 2026. This represents an increase of 2.0% from the same quarter a year earlier. Against the prior quarter it is down 2.7%.

Share Buybacks

$197.0M

YoY-33.9%

QoQ-0.5%

5Y CAGR-23.2%

Deere & Company spent $197.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 33.9% from the same quarter a year earlier. Against the prior quarter it is down 0.5%.

Capital Expenditures

$265.0M

YoY-10.8%

QoQ+35.9%

5Y CAGR+9.0%

10Y CAGR+5.6%

Deere & Company invested $265.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 10.8% from the same quarter a year earlier. Against the prior quarter it is up 35.9%.

DE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DE quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$46.9B	$45.7B-11.7%	$51.7B-15.6%	$61.3B+16.5%	$52.6B+19.4%	$44.0B+23.9%	$35.5B-9.5%	$39.3B+5.1%	$37.4B+25.6%	$29.7B+11.6%	$26.6B-7.7%	$28.9B-20.0%	$36.1B-4.6%	$37.8B+4.5%	$36.2B+12.9%	$32.0B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$19.9B+9.2%	$18.2B-9.4%	$20.1B-18.7%	$24.8B-3.5%	$25.7B+2.6%	$25.0B+14.1%	$21.9B
R&D Expenses	$2.4B	$2.3B+0.9%	$2.3B+5.2%	$2.2B+13.9%	$1.9B+20.5%	$1.6B-3.5%	$1.6B-7.8%	$1.8B+7.5%	$1.7B+20.8%	$1.4B-1.2%	$1.4B-2.5%	$1.4B-1.9%	$1.5B-1.7%	$1.5B+3.0%	$1.4B+16.9%	$1.2B
SG&A Expenses	$4.7B	$4.7B-3.7%	$4.8B+5.3%	$4.6B+18.9%	$3.9B+14.2%	$3.4B-2.7%	$3.5B-2.1%	$3.6B+2.8%	$3.5B+11.5%	$3.1B+12.1%	$2.8B-3.8%	$2.9B-12.5%	$3.3B-8.9%	$3.6B+5.5%	$3.4B+7.8%	$3.2B
Operating Income	N/A	N/A	$9.0B-30.2%	$13.0B+36.3%	$9.5B+18.7%	$8.0B+86.1%	$4.3B-2.5%	$4.4B-1.4%	$4.5B+25.2%	$3.6B+38.0%	$2.6B-17.5%	$3.1B-39.8%	$5.2B-12.0%	$5.9B+16.0%	$5.1B+11.9%	$4.6B
EBITDA	N/A	N/A	$11.2B-25.4%	$15.0B+31.2%	$11.4B+13.3%	$10.1B+56.7%	$6.4B-0.2%	$6.4B+0.5%	$6.4B+21.0%	$5.3B+27.5%	$4.1B-8.3%	$4.5B-30.7%	$6.5B-7.7%	$7.1B+15.6%	$6.1B+11.6%	$5.5B
Interest Expense	$3.0B	$3.2B-5.3%	$3.3B+36.5%	$2.5B+131.0%	$1.1B+6.9%	$993.0M-20.4%	$1.2B-14.9%	$1.5B+21.8%	$1.2B+33.9%	$899.0M+17.7%	$763.7M+12.3%	$680.0M+2.4%	$664.0M-10.4%	$741.3M-5.3%	$782.8M+3.1%	$759.4M
Income Tax	$1.4B	$1.3B-39.9%	$2.1B-27.1%	$2.9B+43.0%	$2.0B+21.0%	$1.7B+53.2%	$1.1B+27.0%	$852.0M-50.7%	$1.7B+77.9%	$971.0M+38.7%	$700.1M-16.7%	$840.1M-48.3%	$1.6B-16.4%	$1.9B+17.3%	$1.7B+16.6%	$1.4B
Net Income	$5.1B	$5.0B-29.2%	$7.1B-30.2%	$10.2B+42.6%	$7.1B+19.6%	$6.0B+116.8%	$2.8B-15.4%	$3.3B+37.4%	$2.4B+9.7%	$2.2B+41.7%	$1.5B-21.4%	$1.9B-38.6%	$3.2B-10.6%	$3.5B+15.4%	$3.1B+9.5%	$2.8B
EPS (Basic)	N/A	$18.55-27.9%	$25.73-26.1%	$34.80+48.6%	$23.42+22.4%	$19.14+118.2%	$8.77-14.7%	$10.28+40.1%	$7.34+8.6%	$6.76+40.0%	$4.83-16.9%	$5.81-33.3%	$8.71-5.1%	$9.18+18.9%	$7.72+15.1%	$6.71
EPS (Diluted)	$18.00	$18.50-27.8%	$25.62-26.0%	$34.63+48.8%	$23.28+22.6%	$18.99+118.5%	$8.69-14.4%	$10.15+40.2%	$7.24+8.4%	$6.68+38.9%	$4.81-16.6%	$5.77-33.1%	$8.63-5.1%	$9.09+19.1%	$7.63+15.1%	$6.63
Diluted Shares (Avg)	N/A	272M-1.9%	277M-5.6%	294M-4.1%	306M-2.5%	314M-0.8%	317M-1.2%	321M-2.0%	327M+1.2%	323M+2.1%	317M-5.8%	336M-8.2%	366M-5.9%	389M-3.1%	402M-4.9%	422M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$12.6B+4.9%	$13.4B+4.7%	$9.6B+13.0%	$11.3B+1.3%	$12.0B-8.6%	$12.8B-16.2%	$8.5B-30.2%	$11.1B-27.7%
R&D Expenses	$567.0M+2.0%	$583.0M+6.2%	$554.0M+5.3%	$652.0M+4.3%	$556.0M-1.9%	$549.0M-2.8%	$526.0M-1.3%	$625.0M+3.0%
SG&A Expenses	$1.2B+0.2%	$1.2B+1.0%	$972.0M0.0%	$1.3B+3.7%	$1.2B-4.8%	$1.2B-5.4%	$972.0M-8.8%	$1.2B+2.3%
Interest Expense	$710.0M-10.6%	$712.0M-9.2%	$719.0M-13.3%	$873.0M+0.3%	$794.0M-5.5%	$784.0M-6.2%	$829.0M+3.4%	$870.0M+11.3%
Income Tax	$529.0M+56.0%	$518.0M-3.9%	$196.0M+625.9%	$185.0M-25.7%	$339.0M-45.8%	$539.0M-28.2%	$27.0M-94.2%	$249.0M-64.8%
Net Income	$1.4B+7.0%	$1.8B-1.7%	$656.0M-24.5%	$1.3B+2.7%	$1.3B-25.7%	$1.8B-23.9%	$869.0M-50.4%	$1.2B-47.4%
EPS (Basic)	$5.11+7.4%	$6.57-1.2%	$2.43-24.1%	$3.94-14.3%	$4.76-24.7%	$6.65-22.3%	$3.20-48.8%	$4.60-44.7%
EPS (Diluted)	$5.10+7.4%	$6.55-1.4%	$2.42-24.1%	$3.93-14.2%	$4.75-24.5%	$6.64-22.2%	$3.19-48.8%	$4.58-44.7%
Diluted Shares (Avg)	271M-0.3%	271M-0.4%	271M-0.5%	N/A	271M-1.5%	272M-2.2%	272M-3.1%	N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Operating Income, EBITDA.

DE Balance Sheet

DE quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$106.0B-1.2%	$107.3B+3.1%	$104.1B+15.6%	$90.0B+7.0%	$84.1B+12.0%	$75.1B+2.8%	$73.0B+4.1%	$70.1B+6.6%	$65.8B+13.6%	$57.9B-0.1%	$57.9B-5.5%	$61.3B+3.0%	$59.5B+5.8%	$56.3B+16.7%	$48.2B
Cash & Equivalents	$8.3B+13.0%	$7.3B-1.8%	$7.5B+56.2%	$4.8B-40.5%	$8.0B+13.5%	$7.1B+83.2%	$3.9B-1.2%	$3.9B-58.2%	$9.3B+115.3%	$4.3B+4.2%	$4.2B+9.9%	$3.8B+8.1%	$3.5B-24.7%	$4.7B+27.6%	$3.6B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$7.4B+4.4%	$7.1B-13.1%	$8.2B-3.9%	$8.5B+25.3%	$6.8B+35.6%	$5.0B-16.3%	$6.0B-2.8%	$6.1B+57.5%	$3.9B+16.9%	$3.3B-12.5%	$3.8B-9.3%	$4.2B-14.7%	$4.9B-4.6%	$5.2B+18.3%	$4.4B
Accounts Receivable	$5.3B-0.2%	$5.3B-31.2%	$7.7B+20.7%	$6.4B+52.3%	$4.2B+0.9%	$4.2B-20.2%	$5.2B+4.5%	$5.0B	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.2B+5.8%	$4.0B+1.5%	$3.9B+5.8%	$3.7B+12.0%	$3.3B+6.8%	$3.1B+5.6%	$2.9B-5.9%	$3.1B+200.2%	$1.0B+26.6%	$816.0M+12.4%	$726.0M-8.2%	$791.0M-6.4%	$845.0M-8.3%	$921.0M-7.9%	$1.0B
Total Liabilities	$80.0B-5.2%	$84.4B+2.7%	$82.2B+18.0%	$69.7B+6.1%	$65.7B+5.7%	$62.1B+0.9%	$61.6B+4.7%	$58.8B+4.6%	$56.2B+9.4%	$51.4B+0.4%	$51.2B-2.1%	$52.3B+6.1%	$49.3B-0.3%	$49.4B+19.4%	$41.4B
Long-Term Debt	N/A	N/A	N/A	N/A	$32.9B+0.5%	$32.7B+8.3%	$30.2B+11.0%	$27.2B+5.2%	$25.9B+9.2%	$23.7B-0.5%	$23.8B-2.2%	$24.4B+13.0%	$21.6B-3.9%	$22.5B+32.4%	$17.0B
Total Equity	$25.9B+13.6%	$22.8B+4.8%	$21.8B+7.5%	$20.3B+9.9%	$18.4B+42.5%	$12.9B+13.4%	$11.4B+1.1%	$11.3B+18.1%	$9.6B+46.6%	$6.5B-3.3%	$6.7B-25.6%	$9.1B-11.7%	$10.3B+50.0%	$6.8B+0.6%	$6.8B
Retained Earnings	$59.7B+5.8%	$56.4B+10.7%	$50.9B+20.6%	$42.2B+15.9%	$36.4B+15.2%	$31.6B+6.0%	$29.9B+8.3%	$27.6B+8.9%	$25.3B+5.8%	$23.9B+3.3%	$23.1B+5.2%	$22.0B+12.0%	$19.6B+16.4%	$16.9B+16.2%	$14.5B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$107.6B-0.2%	$107.0B+0.7%	$103.4B+0.3%	$106.0B-1.2%	$107.8B0.0%	$106.3B+0.6%	$103.1B+1.7%	$107.3B+3.1%
Cash & Equivalents	$8.9B+4.1%	$7.9B-1.1%	$6.8B+3.0%	$8.3B+13.0%	$8.6B+22.5%	$8.0B+43.9%	$6.6B+28.5%	$7.3B-1.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$7.8B+1.3%	$8.2B+4.0%	$8.3B+7.0%	$7.4B+4.4%	$7.7B+0.2%	$7.9B-6.8%	$7.7B-13.3%	$7.1B-13.1%
Accounts Receivable	$7.7B+26.5%	$7.6B+12.2%	$6.0B+21.5%	$5.3B-0.2%	$6.1B-18.3%	$6.7B-24.0%	$4.9B-36.7%	$5.3B-31.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.5B+6.1%	$4.5B+10.2%	$4.3B+10.5%	$4.2B+5.8%	$4.2B+6.3%	$4.1B+4.0%	$3.9B-2.4%	$4.0B+1.5%
Total Liabilities	$79.6B-3.6%	$79.5B-2.9%	$77.1B-4.3%	$80.0B-5.2%	$82.6B-2.5%	$81.9B-1.1%	$80.6B+1.7%	$84.4B+2.7%
Total Equity	$28.0B+11.2%	$27.4B+12.8%	$26.3B+17.0%	$25.9B+13.6%	$25.2B+9.2%	$24.3B+7.1%	$22.5B+1.8%	$22.8B+4.8%
Retained Earnings	$62.2B+5.3%	$61.2B+5.2%	$59.9B+5.4%	$59.7B+5.8%	$59.0B+6.2%	$58.2B+7.3%	$56.8B+8.7%	$56.4B+10.7%

Not reported in any period shown, so not listed: Current Assets, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

DE Cash Flow Statement

DE quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$7.2B	$7.5B-19.2%	$9.2B+7.5%	$8.6B+82.8%	$4.7B-39.2%	$7.7B+3.2%	$7.5B+119.3%	$3.4B+87.3%	$1.8B-17.0%	$2.2B-41.7%	$3.8B+0.3%	$3.8B+6.6%	$3.5B+8.3%	$3.3B+178.7%	$1.2B-49.8%	$2.3B
Depreciation & Amortization	N/A	$2.2B+5.2%	$2.1B+5.7%	$2.0B+5.8%	$1.9B-7.6%	$2.0B-3.2%	$2.1B+4.9%	$2.0B+4.8%	$1.9B+12.3%	$1.7B+10.0%	$1.6B+12.8%	$1.4B+5.8%	$1.3B+14.6%	$1.1B+13.6%	$1.0B+9.8%	$914.9M
Stock-Based Compensation	N/A	$151.0M-27.4%	$208.0M+60.0%	$130.0M+52.9%	$85.0M+3.7%	$82.0M+1.2%	$81.0M-1.2%	$82.0M-2.4%	$84.0M+23.5%	$68.0M-3.7%	$70.6M+6.8%	$66.1M-15.8%	$78.5M-2.7%	$80.7M+8.3%	$74.5M+8.0%	$69.0M
Capital Expenditures	$1.2B	$1.4B-17.1%	$1.6B+9.5%	$1.5B+32.1%	$1.1B+33.7%	$848.0M+3.4%	$820.0M-26.8%	$1.1B+25.0%	$896.0M+50.6%	$595.0M-7.7%	$644.4M-7.1%	$694.0M-33.8%	$1.0B-9.5%	$1.2B-12.2%	$1.3B+24.9%	$1.1B
Free Cash Flow	$6.0B	$6.1B-19.7%	$7.6B+7.1%	$7.1B+98.9%	$3.6B-48.2%	$6.9B+3.2%	$6.7B+190.7%	$2.3B+147.5%	$926.0M-42.2%	$1.6B-48.8%	$3.1B+2.0%	$3.1B+23.7%	$2.5B+18.2%	$2.1B+1483.4%	-$151.5M-111.9%	$1.3B
Investing Cash Flow	-$2.1B	-$2.1B+68.2%	-$6.5B+26.1%	-$8.7B-3.1%	-$8.5B-47.6%	-$5.8B-73.2%	-$3.3B+15.4%	-$3.9B+52.0%	-$8.2B-391.9%	-$1.7B-41.2%	-$1.2B-11.2%	-$1.1B	N/A	N/A	N/A	-$2.6B
Financing Cash Flow	-$4.8B	-$4.6B-68.5%	-$2.7B-196.8%	$2.8B+240.0%	$826.0M+176.6%	-$1.1B-10.0%	-$980.0M-292.5%	$509.0M-41.9%	$876.0M-79.6%	$4.3B+278.1%	-$2.4B-12.6%	-$2.1B	N/A	N/A	N/A	$139.6M
Dividends Paid	$1.8B	$1.7B+7.2%	$1.6B+12.5%	$1.4B+8.7%	$1.3B+26.3%	$1.0B+8.8%	$956.0M+1.4%	$943.0M+17.0%	$806.0M+5.5%	$764.0M+0.4%	$761.3M-6.7%	$816.3M+3.9%	$786.0M+4.4%	$752.9M+7.9%	$697.9M+17.7%	$593.1M
Share Buybacks	$699.0M	$1.1B-71.6%	$4.0B-44.5%	$7.2B+100.6%	$3.6B+41.7%	$2.5B+238.4%	$750.0M-40.1%	$1.3B+30.8%	$958.0M+15866.7%	$6.0M-97.1%	$205.4M-92.6%	$2.8B+1.4%	$2.7B+78.3%	$1.5B-3.5%	$1.6B-4.8%	$1.7B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$2.2B-23.8%	$1.9B+13.6%	-$890.0M+21.4%	$4.0B-21.5%	$2.9B-9.4%	$1.7B-8.2%	-$1.1B-24.7%	$5.1B-10.6%
Depreciation & Amortization	$603.0M+6.9%	$594.0M+7.0%	$590.0M+7.5%	$561.0M+7.9%	$564.0M+2.0%	$555.0M+5.7%	$549.0M+5.6%	$520.0M+9.0%
Stock-Based Compensation	N/A	N/A	$41.0M+46.4%	N/A	N/A	N/A	$28.0M-39.1%	N/A
Capital Expenditures	$265.0M-10.8%	$195.0M-3.9%	$256.0M-27.3%	$508.0M-14.9%	$297.0M-8.3%	$203.0M-43.1%	$352.0M-2.8%	$597.0M-2.3%
Free Cash Flow	$1.9B-25.2%	$1.7B+16.0%	-$1.1B+22.8%	$3.5B-22.4%	$2.6B-9.5%	$1.5B+0.1%	-$1.5B-16.9%	$4.5B-11.6%
Investing Cash Flow	-$918.0M+41.9%	-$1.7B-171.4%	$1.8B+28.7%	-$1.3B+55.0%	-$1.6B+21.0%	-$637.0M+77.9%	$1.4B+16.4%	-$2.8B+33.3%
Financing Cash Flow	-$201.0M+72.7%	$863.0M+746.1%	-$2.5B-169.8%	-$3.0B-56.7%	-$736.0M-297.3%	$102.0M-93.1%	-$923.0M+65.1%	-$1.9B-237.7%
Dividends Paid	$438.0M-0.2%	$437.0M-0.7%	$441.0M+9.4%	$438.0M+8.7%	$439.0M+8.1%	$440.0M+7.3%	$403.0M+4.4%	$403.0M+11.3%
Share Buybacks	$197.0M-33.9%	$198.0M-50.1%	$302.0M-31.5%	$2.0M-99.7%	$298.0M-63.0%	$397.0M-63.7%	$441.0M-66.8%	$780.0M-69.4%

DE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DE quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	N/A	17.5%-3.7pp	21.2%+3.1pp	18.1%-0.1pp	18.2%+6.1pp	12.1%+0.9pp	11.3%-0.7pp	12.0%0.0pp	12.0%+2.3pp	9.7%-1.2pp	10.9%-3.6pp	14.5%-1.2pp	15.7%+1.5pp	14.1%-0.1pp	14.3%
Net Margin	11.0%-2.7pp	13.7%-2.9pp	16.6%+3.0pp	13.6%0.0pp	13.5%+5.8pp	7.7%-0.6pp	8.3%+2.0pp	6.3%-0.9pp	7.3%+1.5pp	5.7%-1.0pp	6.7%-2.1pp	8.8%-0.6pp	9.4%+0.9pp	8.5%-0.3pp	8.8%
Return on Equity	19.4%-11.7pp	31.1%-15.6pp	46.7%+11.5pp	35.2%+2.8pp	32.4%+11.1pp	21.3%-7.2pp	28.5%+7.5pp	21.0%-1.6pp	22.6%-0.8pp	23.4%-5.4pp	28.8%-6.1pp	34.9%+0.4pp	34.5%-10.3pp	44.8%+3.6pp	41.2%
Return on Assets	4.7%-1.9pp	6.6%-3.1pp	9.8%+1.8pp	7.9%+0.8pp	7.1%+3.4pp	3.7%-0.8pp	4.5%+1.1pp	3.4%+0.1pp	3.3%+0.7pp	2.6%-0.7pp	3.4%-1.8pp	5.1%-0.8pp	5.9%+0.5pp	5.5%-0.4pp	5.8%
Debt-to-Equity	3.08-0.6x	3.70-0.1x	3.77+0.3x	3.44+1.7x	1.78-0.7x	2.53-0.1x	2.65+0.2x	2.41-0.3x	2.71-0.9x	3.64+0.1x	3.53+0.8x	2.69+0.6x	2.10-1.2x	3.28+0.8x	2.49
Asset Turnover	0.43-0.1x	0.48-0.1x	0.590.0x	0.58+0.1x	0.52+0.1x	0.47-0.1x	0.540.0x	0.53+0.1x	0.450.0x	0.460.0x	0.50-0.1x	0.590.0x	0.640.0x	0.640.0x	0.66
FCF Margin	13.4%-1.3pp	14.7%+3.1pp	11.6%+4.8pp	6.8%-8.8pp	15.6%-3.1pp	18.8%+12.9pp	5.8%+3.4pp	2.5%-2.9pp	5.4%-6.3pp	11.7%+1.1pp	10.6%+3.8pp	6.9%+1.3pp	5.5%+6.0pp	-0.4%-4.4pp	4.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Net Margin	10.9%+0.2pp	13.3%-0.9pp	6.8%-3.4pp	11.3%+0.2pp	10.7%-2.4pp	14.1%-1.4pp	10.2%-4.2pp	11.2%-4.2pp
Return on Equity	4.9%-0.2pp	6.5%-1.0pp	2.5%-1.4pp	4.9%-0.5pp	5.1%-2.4pp	7.4%-3.0pp	3.9%-4.1pp	5.5%-5.4pp
Return on Assets	1.3%+0.1pp	1.7%0.0pp	0.6%-0.2pp	1.2%+0.1pp	1.2%-0.4pp	1.7%-0.5pp	0.8%-0.9pp	1.2%-1.1pp
Debt-to-Equity	2.84-0.4x	2.90-0.5x	2.93-0.7x	3.08-0.6x	3.28-0.4x	3.37-0.3x	3.580.0x	3.70-0.1x
Asset Turnover	0.120.0x	0.120.0x	0.090.0x	0.110.0x	0.110.0x	0.120.0x	0.080.0x	0.100.0x
FCF Margin	15.4%-6.2pp	13.0%+1.3pp	-11.9%+5.5pp	30.9%-9.5pp	21.6%-0.2pp	11.7%+1.9pp	-17.4%-7.0pp	40.3%+7.4pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Deere & Company DE	FY2025	$45.7B	$5.0B	11.0%	$167.4B	32/100
Paccar Inc PCAR	FY2025	$28.4B	$2.4B	8.3%	$56.9B	20/100
Caterpillar Inc. CAT	FY2025	$67.6B	$8.9B	13.1%	$368.0B	59/100
CNH INDUSTRIAL N.V. CNH	FY2025	$18.1B	$510.0M	2.8%	$18.3B	3/100
AGCO Corporation AGCO	FY2025	$10.1B	$726.5M	7.2%	$7.2B	39/100
Terex Corporation TEX	FY2025	$5.4B	$221.0M	4.1%	$5.8B	54/100

Where Deere & Company Ranks

Frequently Asked Questions

What is Deere & Company's annual revenue?

Deere & Company (DE) reported $45.7B in total revenue for fiscal year 2025. This represents a -11.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Deere & Company's revenue growing?

Deere & Company (DE) revenue declined by 11.7% year-over-year, from $51.7B to $45.7B in fiscal year 2025.

Is Deere & Company profitable?

Yes, Deere & Company (DE) reported a net income of $5.0B in fiscal year 2025, with a net profit margin of 11.0%.

What is Deere & Company's net profit margin?

Deere & Company (DE) had a net profit margin of 11.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Deere & Company pay dividends?

Yes, Deere & Company (DE) paid $6.48 per share in dividends during fiscal year 2025.

What is Deere & Company's return on equity (ROE)?

Deere & Company (DE) has a return on equity of 19.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Deere & Company's free cash flow?

Deere & Company (DE) generated $6.1B in free cash flow during fiscal year 2025. This represents a -19.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Deere & Company's operating cash flow?

Deere & Company (DE) generated $7.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Deere & Company's total assets?

Deere & Company (DE) had $106.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Deere & Company's capital expenditures?

Deere & Company (DE) invested $1.4B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Deere & Company spend on research and development?

Deere & Company (DE) invested $2.3B in research and development during fiscal year 2025.

Does Deere & Company buy back shares?

Yes, Deere & Company (DE) spent $1.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Deere & Company have outstanding?

Deere & Company (DE) had 270M shares outstanding as of fiscal year 2025.

What is Deere & Company's debt-to-equity ratio?

Deere & Company (DE) had a debt-to-equity ratio of 3.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Deere & Company's return on assets (ROA)?

Deere & Company (DE) had a return on assets of 4.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Deere & Company's P/E ratio?

Deere & Company (DE) trades at 32.9x earnings, its market capitalization divided by net income of $5.1B net income, trailing 12 months to August 2, 2026. The market capitalization is $167.4B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Deere & Company's price-to-sales ratio?

Deere & Company (DE) trades at 3.6x sales, its market capitalization divided by revenue of $46.9B revenue, trailing 12 months to August 2, 2026. The market capitalization is $167.4B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Deere & Company's Piotroski F-Score?

Deere & Company (DE) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Deere & Company's earnings high quality?

Deere & Company (DE) has an earnings quality ratio of 1.48x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Deere & Company?

Deere & Company (DE) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.